Marija Stanković

Senior Research Associate
Laboratory for Molecular Biology (LMB)

Institute of molecular genetics and genetic engineering (IMGGE),
University of Belgrade (UB)

V. Stepe 444a, P.Fah 23, 11010 Belgrade, Serbia
Mobile:  +381 65 397 66 58                                   
Phone:  +381 11 397 66 58
Fax:      +381 11 397 58 08
E-mail: marijast@imgge.bg.ac.rs

EDUCATION

2010 - PhD in Molecular Biology, Faculty of Biology (FB), UB
(THESIS: Analysis of gene variants in chronic obstructive pulmonary disease in humans)
2003 - BSc in Molecular Biology and Physiology, Faculty of Biology, University of Belgrade (Applied Genetics)

RESEARCH EXPERIENCE

2018 Senior Research Associate LMB, IMGGE
2013 - 2015 - Postdoctoral Fellowship by the Feinberg Graduate School, Weizmann Institute of Science, Israel
2011 2018 - Research Associate LMB, IMGGE, University of Belgrade
2007 - 2011 - Research Assistant LMB, IMGGE, University of Belgrade
2004 - 2007 - Research Trainee LMB, IMGGE, University of Belgrade
2003 - 2004 - Postgraduate Fellowship by the Ministry of Science and Environmental Protection, Republic of Serbia

CAREER HISTORY

2013 - 2015 - Postdoctoral Fellow, Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel
2011 - 2012 - Assistant Coordinator: Complex Diseases as a Model System for Phenotype Modulation - Structural and Functional Analysis of Molecular Biomarkers - Pulmonary Phenotype, MESTDS 173008
2011 – 2012 Lecturer on PhD Programme in Molecular Biology, Faculty of Biology, University of Belgrade, Subject: Molecular Genetic in the Diagnostic, Prevention and Therapy of Human Diseases
2003 - LMB, IMGGE, University of Belgrade

RESEARCH INTEREST

My scientific interest is focused on chronic lung disorders including COPD, bronchiectasis, emphysema and fibrosis, with specific attention towards genetic and molecular aspects of inflammation, oxidative stress, metabolism of xenobiotics and remodeling of extracellular matrix. Particularly my curiosity is directed to understanding the role of genetic mechanisms such as gene variations, gene expressions, regulation of gene expression, gene-gene and gene-environment interactions, as well as epigenetic mechanisms, in the occurrence of lung lessons.

SELECTED PUBLICATIONS

Gene-Gene Interactions Between Glutathione S-Transferase M1 and Matrix Metalloproteinases 1, 9, and 12 in Chronic Obstructive Pulmonary Disease in Serbians.  Stankovic M, Nikolic A, Nagorni-Obradovic L, Petrovic-Stanojevic N, Radojkovic D.  COPD. 2017;14(6):581-589.
https://www.ncbi.nlm.nih.gov/pubmed/28949773 

Oxidative stress and genetic variants of xenobiotic-metabolising enzymes associated with COPD development and severity in Serbian adults. Malic Z, Topic A, Francuski D, Stankovic M, Nagorni-Obradovic L, Markovic B, Radojkovic D. COPD. 2017;14(1):95-104.
https://www.ncbi.nlm.nih.gov/pubmed/27421065

Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease. Stankovic M, Kojic S, Djordjevic V, Tomovic A, Nagorni-Obradovic L, Petrovic-Stanojevic N, Mitic-Milikic M, Radojkovic D. Environ Mol Mutagen. 2016;57(6):447-54.
https://www.ncbi.nlm.nih.gov/pubmed/27270564 

Gender-related differences in susceptibility to oxidative stress in healthy middle-aged Serbian adults. Topic A, Malic Z, Francuski D, Stankovic M, Markovic B, Soskic B, Tomic B, Ilic S, Dobrivojevic S, Drca S, Radojkovic D. Biomarkers. 2016;21(2):186-93.
https://www.ncbi.nlm.nih.gov/pubmed/26754535 

Association of functional variants of phase I and II genes with chronic obstructive pulmonary disease in Serbian population. Stankovic M, Nikolic A, Tomovic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Radojkovic D. J Med Biochem. 2015;34(2): 207–214.
https://www.ncbi.nlm.nih.gov/pubmed/28356833 

Polymorphisms of beta2-adrenergic receptor gene in Serbian asthmatic adults: effects on response to beta-agonists. Petrovic-Stanojevic N, Topic A, Nikolic A, Stankovic M, Dopudja-Pantic V, Milenkovic B, Radojkovic D. Mol Diagn Ther. 2014;18(6):639–646.
https://www.ncbi.nlm.nih.gov/pubmed/25074500 

Gender-related reference intervals of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine determined by liquid chromatography-tandem mass spectrometry in Serbian population. Topic A, Francuski D, Markovic B, Stankovic M, Dobrivojevic S, Drca S, Radojkovic D. Clin Biochem. 2013;46(4-5):321-6.
http://www.ncbi.nlm.nih.gov/pubmed/23261837 

Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Topic A, Stankovic M, Divac-Rankov A, Petrovic-Stanojevic N, Mitic-Milikic M, Radojkovic D. Genet Test Mol Biomarkers. 2012;16(11):1282-6.
http://www.ncbi.nlm.nih.gov/pubmed/22971141 

Therapeutic Potential of NO-Modified Drugs in Colon Cancer Cells. Mojic M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Stosic-Grujicic S, Stankovic M, Mangano K, Travali S, Donia M, Fagone P, Zocca MB, Al-Abed Y, McCubrey JA, Nicoletti F. Mol Pharmacol. 2012;82(4):700-10.
http://www.ncbi.nlm.nih.gov/pubmed/22798453 

Prothrombotic genetic risk factors in stroke: a possible different role in pediatric and adult patients. Djordjevic V, Stankovic M, Brankovic-Sreckovic V, RakicevicLj, Damnjanovic T, Antonijevic N, Radojkovic D. Clin Appl Thromb Hemost. 2012;18(6):658-61.
http://www.ncbi.nlm.nih.gov/pubmed/22275392

Uloga genetičkih faktora u hroničnoj opstruktivnoj bolesti pluća. Stanković M, Radojković D. u Hronična opstruktivna bolest pluća, Univerzitet u Beogradu, Medicinski fakultet, Beograd. Urednik: Bošnjak-Petrović V, 2011, 39-55.

A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac A, Faulkner G. Arch Biochem Biophys. 2010;502(1):60-7.
http://www.ncbi.nlm.nih.gov/pubmed/20599664 

TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Stankovic M, Nestorovic A, Tomovic A, Petrovic-Stanojevic N, Andjelic-Jelic M, Dopudja-Pantic V, Nagorni-Obradovic Lj, Mitic-Milikic M, Radojkovic D. Neoplasma. 2009;56(4):348-52.
http://www.ncbi.nlm.nih.gov/pubmed/19469656 

Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis. Stankovic M, Nikolic A, Divac A, Rakicevic Lj, Tomovic A, Mitic-Milikic M, Nagorni-Obradovic Lj, Grujic M,Petrovic-Stanojevic N, Andjelic-Jelic M, Dopudja-Pantic V, Radojkovic D. J Investig Med. 2009;57(3):500-503.
http://www.ncbi.nlm.nih.gov/pubmed/19188843 

Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay? Djordjevic V, Stankovic M, Brankovic-Sreckovic V, RakicevicLj, Radojkovic D. J Child Neurol. 2009;24(7):823-7.
http://www.ncbi.nlm.nih.gov/pubmed/19372095 

The CFTR M470V gene variant as a potential modifier of COPD severity: study of Serbian population. Stankovic M,Nikolic A,Divac A,Tomovic A,Petrovic-Stanojevic N,Andjelic M,Dopudja-Pantic V,Surlan M,Vujicic I,Ponomarev D,Mitic-Milikic M,Kusic JRadojkovic D. Genet Test. 2008;12(3):357.
http://www.ncbi.nlm.nih.gov/pubmed/18652532 

Indirect diagnosis of haemophilia B by multiplex PCR/RFLP. Stankovic M, Rakicevic L, Mikovic D, Jankovic G, Nikolic A. Clin Lab Haematol. 2005;27(2):145.
http://www.ncbi.nlm.nih.gov/pubmed/15784132 

Please publish modules in offcanvas position.